Discover 282 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Dakota offers a range of options for both healthy volunteers interested in paid clinical studies and individuals with specific health conditions. Major research hubs in Sioux Falls, Rapid City, and Aberdeen are currently recruiting participants, allowing access to groundbreaking treatments and advanced medical support.
Filter
1
Filter results
Results: 282
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Montreal, Winston-Salem NC, Pittsburgh PA, Charlotte NC,
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase3, Recruiting
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
for
Ovarian Cancer, Ovarian Cancer Recurrent
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Compugen Ltd
Sex: Female
Age: 18+
Code: NCT06888921
Phase1, Phase2, Recruiting
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
for
Head and Neck Squamous Cell Carcinoma
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06163534
Recruiting
A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects
for
Presbyopia, Pseudophakia
Location: Bowie MD, Bradenton FL, Largo FL, Brecksville OH,
Sponsor: ReVision Optics, Inc.
Sex: All
Age: 50+
Code: NCT02668523
Phase3, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Haven CT, The Bronx NY, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase2, Recruiting
An Observational, Qualitative Study Assessing Eye Drop Administration
for
Ocular Injury
Location: Sioux Falls SD
Sponsor: Ocular Therapeutix, Inc.
Sex: All
Age: 0+
Code: NCT05307081
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Augusta ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase3, Recruiting
Melodi Matrix™ in Breast Reconstruction
for
Breast Reconstruction
Location: Staten Island NY, Charleston SC, Pittsburgh PA,
Sponsor: Melodi Health, Inc.
Sex: Female
Age: 22+
Code: NCT06027996
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Halifax, Moncton, Rimouski, Farmington CT, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
PTSD, AUD, and Interpersonal Conflict: Within-person Associations
for
Stress Disorders, Post-Traumatic, Alcoholism
Location: Sioux Falls SD, Vermillion SD
Sponsor: University of South Dakota
Sex: All
Age: 18 - 60
Code: NCT04552782
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, Shirley NY, New Haven CT, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase1, Phase2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Boston MA, New Haven CT, New York NY, Morristown NJ,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
for
Locally Advanced Hepatocellular Carcinoma,
Location: Buffalo NY, Pittsburgh PA, Ann Arbor MI, Milwaukee WI,
Sponsor: Academic and Community Cancer Research United